| The FTSE Med Index Committee approved the following changes to the FTSE Med 100 Index. The changes will be effective after the close of business on Friday, 19 May 2006 (i.e. on Monday, 22 May 2006). |
PERIODIC REVIEW OF CONSTITUENTS Additions to the FTSE Med 100 Index: | Stock Name | Sedol | Country | Rank | Investability Weight (%) | Reason | | Muskita Aluminium Industries | 5955020 | Cyprus | 119 | 40 | Exchange Balancing Addition |
Deletions from the FTSE Med 100 Index: | Stock Name | Sedol | Country | Reason | | Vision International | B01FLM2 | Cyprus | Auto Deletion |
Reserve list for the FTSE Med 100 Index: With immediate effect, the following reserve list will be used in the event that one or more constituents are deleted during the period up to the next semi-annual review: | Stock Name | Sedol | Country | Rank | Investability Weight (%) | | Athens Medical C.S.A | 4056612 | Greece | 83 | 40 | | Halkor S.A. | 5266142 | Greece | 89 | 30 | | Iaso | 5950779 | Greece | 92 | 100 | | Aladdin Knowledge Systems | B02H912 | Israel | 96 | 75 | | Minoan Lines (Cr) | 5447754 | Greece | 97 | 100 |
For index related enquiries or further information about FTSE please contact: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | Tel: +1 888 747 FTSE (3873) or +1 212 641 6165 | | Client Services in Asia Pacific: | Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811 |
Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com | 